Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study To Assess The Ability Of Neoadjuvant Chemotherapy Plus/Minus Second Look Surgery To Eliminate All Measurable Disease Prior To Radiotherapy For NGGCT

NCT00047320 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00047320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00047320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study To Assess The Ability Of Neoadjuvant Chemotherapy Plus/Minus Second Look Surgery To Eliminate All Measurable Disease Prior To Radiotherapy For NGGCT
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2004
Completion date
February 28, 2009
Enrollment
104 (actual)
Sites
106

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, central nervous system tumors, childhood germ cell tumor